10-K Filing

IDEXX LABORATORIES INC /DE CIK: 874716 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0000874716-18-000005`
Period End Date	20171231
Filing Date	20180216
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	idxx-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 87 Income Statement 115 Cash Flow Statement 94 Stockholders Equity 29 Comprehensive Income 41

Balance Sheet 87 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.58M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.52M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$187.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$154.90M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$284.25M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	103.34M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$236.95M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	104.28M	shares	Point-in-time
Accounts receivable, net of reserves of $4,576 in 2017 and $4,523 in 2016	`AccountsReceivableNetCurrent`	$204.49M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	231,000.00	shares	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	229,000.00	shares	Point-in-time
Accounts receivable, net of reserves of $4,576 in 2017 and $4,523 in 2016	`AccountsReceivableNetCurrent`	$234.60M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	15.37M	shares	Point-in-time
Inventories	`InventoryNet`	$158.03M	USD	Point-in-time
Inventories	`InventoryNet`	$164.32M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	17.17M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$101.14M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$91.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$971.99M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$845.58M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$357.42M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$379.10M	USD	Point-in-time
Goodwill	`Goodwill`	$178.93M	USD	Point-in-time
Goodwill	`Goodwill`	$184.45M	USD	Point-in-time
Goodwill	`Goodwill`	$199.87M	USD	Point-in-time
Goodwill	`Goodwill`	$178.23M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$46.16M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$43.85M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$118.62M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$103.31M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$741.43M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$685.12M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.53B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.71B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$66.97M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$60.06M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$236.13M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$253.42M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$611.00M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$655.00M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$27.38M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$29.18M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.00B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$934.57M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$25.35M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$39.29M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$606.08M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$593.11M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$33.02M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$35.55M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$95.72M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$38.94M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$704.35M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$762.69M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.64B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.77B	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 104,275 shares in 2017 and 103,341 shares in 2016	`CommonStockValue`	$10.43M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 104,275 shares in 2017 and 103,341 shares in 2016	`CommonStockValue`	$10.33M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.01B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.07B	USD	Point-in-time
Deferred stock units: Outstanding: 229 units in 2017 and 231 units in 2016	`CommonStockOtherValueOutstanding`	$5.99M	USD	Point-in-time
Deferred stock units: Outstanding: 229 units in 2017 and 231 units in 2016	`CommonStockOtherValueOutstanding`	$5.51M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$803.54M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$540.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-36.47M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-42.27M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-43.05M	USD	Point-in-time
Treasury stock, at cost: 17,171 shares in 2017 and 15,367 shares in 2016	`TreasuryStockValue`	$1.91B	USD	Point-in-time
Treasury stock, at cost: 17,171 shares in 2017 and 15,367 shares in 2016	`TreasuryStockValue`	$1.63B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$-108.35M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$-54.11M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$139.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$264.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$117.59M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.84M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-108.21M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.71B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.53B	USD	Point-in-time

Income Statement 115 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueGoodsNet`	$1.18B	USD	Annual
Product revenue	`SalesRevenueGoodsNet`	$1.07B	USD	Annual
Product revenue	`SalesRevenueGoodsNet`	$974.93M	USD	Annual
Service revenue	`SalesRevenueServicesNet`	$626.96M	USD	Annual
Service revenue	`SalesRevenueServicesNet`	$792.94M	USD	Annual
Service revenue	`SalesRevenueServicesNet`	$704.45M	USD	Annual
Total revenue	`SalesRevenueNet`	$466.57M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$417.55M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$448.31M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$506.12M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.78B	USD	Annual
Total revenue	`SalesRevenueNet`	$1.60B	USD	Annual
Total revenue	`SalesRevenueNet`	$508.94M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$491.98M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$443.00M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.97B	USD	Annual
Total revenue	`SalesRevenueNet`	$462.02M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$416.81M	USD	Annual
Cost of product revenue	`CostOfGoodsSold`	$446.45M	USD	Annual
Cost of product revenue	`CostOfGoodsSold`	$360.21M	USD	Annual
Cost of service revenue	`CostOfServices`	$351.41M	USD	Annual
Cost of service revenue	`CostOfServices`	$383.18M	USD	Annual
Cost of service revenue	`CostOfServices`	$425.23M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$871.68M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$711.62M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$799.99M	USD	Annual
Gross profit	`GrossProfit`	$292.71M	USD	1 Quarter
Gross profit	`GrossProfit`	$975.44M	USD	Annual
Gross profit	`GrossProfit`	$227.54M	USD	1 Quarter
Gross profit	`GrossProfit`	$240.63M	USD	1 Quarter
Gross profit	`GrossProfit`	$260.54M	USD	1 Quarter
Gross profit	`GrossProfit`	$272.47M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.10B	USD	Annual
Gross profit	`GrossProfit`	$246.73M	USD	1 Quarter
Gross profit	`GrossProfit`	$258.19M	USD	1 Quarter
Gross profit	`GrossProfit`	$890.27M	USD	Annual
Gross profit	`GrossProfit`	$274.00M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$354.29M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$317.06M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$299.95M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$182.51M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$220.88M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$207.02M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$109.18M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$101.12M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$99.68M	USD	Annual
Impairment charge	`ImpairmentOfIntangibleAssetsFinitelived`	$8.21M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$73.79M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$413.03M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$100.41M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$104.16M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$299.91M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$350.24M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$97.81M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$92.24M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$122.56M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$88.46M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$83.83M	USD	1 Quarter
Interest expense	`InterestExpense`	$37.23M	USD	Annual
Interest expense	`InterestExpense`	$32.05M	USD	Annual
Interest expense	`InterestExpense`	$29.24M	USD	Annual
Interest income	`InterestAndOtherIncome`	$2.47M	USD	Annual
Interest income	`InterestAndOtherIncome`	$5.25M	USD	Annual
Interest income	`InterestAndOtherIncome`	$3.66M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$273.14M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$321.85M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$381.06M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$99.79M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$81.01M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$117.79M	USD	Annual
Net income	`ProfitLoss`	$263.27M	USD	Annual
Net income	`ProfitLoss`	$192.13M	USD	Annual
Net income	`ProfitLoss`	$222.05M	USD	Annual
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$125.00K	USD	Annual
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$57.00K	USD	Annual
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.00K	USD	Annual
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$69.02M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$263.14M	USD	Annual
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$46.02M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$222.04M	USD	Annual
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$85.36M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$67.20M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$56.45M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$70.51M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$192.08M	USD	Annual
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$52.37M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$38.26M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.75	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.81	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.63	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.97	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$2.47	USD	Annual
Basic	`EarningsPerShareBasic`	$3.00	USD	Annual
Basic	`EarningsPerShareBasic`	$0.78	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.59	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$2.07	USD	Annual
Basic	`EarningsPerShareBasic`	$0.51	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.44	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.58	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.79	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.43	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.77	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.95	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$2.05	USD	Annual
Diluted	`EarningsPerShareDiluted`	$2.44	USD	Annual
Diluted	`EarningsPerShareDiluted`	$2.94	USD	Annual
Diluted	`EarningsPerShareDiluted`	$0.62	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.74	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.51	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.60M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	87.77M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	89.73M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.88M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	89.57M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.65M	shares	Annual

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$263.27M	USD	Annual
Net income	`ProfitLoss`	$192.13M	USD	Annual
Net income	`ProfitLoss`	$222.05M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$68.96M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$78.22M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$83.14M	USD	Annual
Amortization on marketable securities, net	`AmortizationOfDebtDiscountPremium`	$843.00K	USD	Annual
Amortization on marketable securities, net	`AmortizationOfDebtDiscountPremium`	$38.00K	USD	Annual
Amortization on marketable securities, net	`AmortizationOfDebtDiscountPremium`	$1.43M	USD	Annual
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$8.21M	USD	Annual
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.23M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$2.20M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$1.88M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$1.17M	USD	Annual
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$20.88M	USD	Annual
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$5.14M	USD	Annual
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-7.92M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$19.88M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$19.89M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$23.52M	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$-472.00K	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$969.00K	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$986.00K	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$14.70M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$11.31M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$24.92M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$22.55M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$50.14M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$34.97M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-7.65M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$19.06M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$2.12M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.39M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-2.47M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$3.55M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-319.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$7.67M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-47.42M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-23.52M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-12.49M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$221.80M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$338.94M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$373.28M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.38M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$64.79M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$82.92M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$227.89M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$271.96M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$334.16M	USD	Annual
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$286.76M	USD	Annual
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$56.77M	USD	Annual
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$203.86M	USD	Annual
Acquisitions of intangible assets	`PaymentsToAcquireIntangibleAssets`	$2.32M	USD	Annual
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.96M	USD	Annual
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.30M	USD	Annual
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$14.58M	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-138.69M	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-90.79M	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-308.41M	USD	Annual
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$38.00M	USD	Annual
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$44.00M	USD	Annual
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$24.00M	USD	Annual
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$250.10M	USD	Annual
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$56.00K	USD	Annual
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$1.38M	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$282.56M	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$401.98M	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$304.09M	USD	Annual
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$22.40M	USD	Annual
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$38.34M	USD	Annual
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$38.62M	USD	Annual
Payment of acquisition-related contingent consideration	`PaymentsOfMergerRelatedCostsFinancingActivities`	$4.73M	USD	Annual
Shares withheld for statutory tax withholding on restricted stock (Note 2)	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.37M	USD	Annual
Shares withheld for statutory tax withholding on restricted stock (Note 2)	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.07M	USD	Annual
Shares withheld for statutory tax withholding on restricted stock (Note 2)	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.44M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$14.70M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$11.31M	USD	Annual
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-222.20M	USD	Annual
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-100.99M	USD	Annual
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-208.02M	USD	Annual
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.95M	USD	Annual
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$6.20M	USD	Annual
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-54.00K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$32.77M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$25.91M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-193.54M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$187.68M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$154.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$187.68M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$154.90M	USD	Point-in-time

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$117.59M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.84M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-108.21M	USD	Point-in-time
Balance, shares	`CommonStockSharesIssued`	103.34M	shares	Point-in-time
Balance, shares	`CommonStockSharesIssued`	104.28M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$263.27M	USD	Annual
Net income (loss)	`ProfitLoss`	$192.13M	USD	Annual
Net income (loss)	`ProfitLoss`	$222.05M	USD	Annual
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-34.19M	USD	Annual
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$6.58M	USD	Annual
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-788.00K	USD	Annual
Repurchases of common stock	`StockholdersEquityOther`	$-412.17M	USD	Annual
Repurchases of common stock	`StockholdersEquityOther`	$-317.03M	USD	Annual
Repurchases of common stock	`StockholdersEquityOther`	$-278.08M	USD	Annual
Common stock issued under stock plans, including excess tax benefit, value	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$32.76M	USD	Annual
Common stock issued under stock plans, including excess tax benefit, value	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$39.10M	USD	Annual
Common stock issued under stock plans, including excess tax benefit, value	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$51.98M	USD	Annual
Deferred stock units activity	`IssuanceVestingAndSettlementOfDeferredStockUnits`	$-329.00K	USD	Annual
Deferred stock units activity	`IssuanceVestingAndSettlementOfDeferredStockUnits`	$-12.00K	USD	Annual
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.88M	USD	Annual
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.89M	USD	Annual
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$23.52M	USD	Annual
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$117.59M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.84M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-108.21M	USD	Point-in-time
Balance, shares	`CommonStockSharesIssued`	103.34M	shares	Point-in-time
Balance, shares	`CommonStockSharesIssued`	104.28M	shares	Point-in-time

Comprehensive Income 41 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$263.27M	USD	Annual
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$113.00K	USD	Annual
Net income	`ProfitLoss`	$192.13M	USD	Annual
Net income	`ProfitLoss`	$222.05M	USD	Annual
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-93.00K	USD	Annual
Unrealized (loss) gain, net of tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$3.74M	USD	Annual
Unrealized (loss) gain, net of tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$2.17M	USD	Annual
Unrealized (loss) gain, net of tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-5.30M	USD	Annual
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$949.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$25.11M	USD	Annual
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$5.85M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.72M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.87M	USD	Annual
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$224.00K	USD	Annual
Unrealized gain (loss) on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$2.14M	USD	Annual
Unrealized gain (loss) on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$1.89M	USD	Annual
Unrealized gain (loss) on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-8.35M	USD	Annual
Unrealized gain (loss) on investments, net of tax expense (benefit) of $- in 2017, $113 in 2016 and ($93) in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-226.00K	USD	Annual
Unrealized gain (loss) on investments, net of tax expense (benefit) of $- in 2017, $113 in 2016 and ($93) in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$245.00K	USD	Annual
Unrealized gain (loss) on investments, net of tax expense (benefit) of $- in 2017, $113 in 2016 and ($93) in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-42.00K	USD	Annual
Unrealized (loss) gain, net of tax (benefit) expense of ($5,304) in 2017, $2,174 in 2016 and $3,736 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$4.95M	USD	Annual
Unrealized (loss) gain, net of tax (benefit) expense of ($5,304) in 2017, $2,174 in 2016 and $3,736 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-10.33M	USD	Annual
Unrealized (loss) gain, net of tax (benefit) expense of ($5,304) in 2017, $2,174 in 2016 and $3,736 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$8.84M	USD	Annual
Less: reclassification adjustment for losses (gains) included in net income, net of tax expense of $224 in 2017, $949 in 2016 and $5,853 in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$2.25M	USD	Annual
Less: reclassification adjustment for losses (gains) included in net income, net of tax expense of $224 in 2017, $949 in 2016 and $5,853 in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$13.98M	USD	Annual
Less: reclassification adjustment for losses (gains) included in net income, net of tax expense of $224 in 2017, $949 in 2016 and $5,853 in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$-197.00K	USD	Annual
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$2.70M	USD	Annual
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-10.13M	USD	Annual
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-5.14M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-34.19M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$6.58M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-788.00K	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$269.85M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$157.94M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$221.27M	USD	Annual
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$9.00K	USD	Annual
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$125.00K	USD	Annual
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$57.00K	USD	Annual
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$221.26M	USD	Annual
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$269.73M	USD	Annual
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$157.88M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.